coHOrte fraNcaise Des dEfibrillateurs Sous cuTanés
Implantable cardioverter-defibrillators have been proven to be effective in the prevention of sudden cardiac death in high-risk patients. However, it is well acknowledged that such a strategy could be optimised, especially through new technologies/devices. Data on the entirely sub-cutaneous implantable cardioverter defibrillator (S-ICD) published so far come from high-volume centers and/or selected populations. The HONEST Cohort -taking the opportunity of a unique scenario with a single manufacturer and remote monitoring system available- aims to collect retrospectively baseline information as well as follow-up of all patients implanted with an S-ICD in France since the first implant in October 13, 2012 until December 31, 2019. An extended prospective yearly follow-up will be carried out since January 1, 2020 until December 31, 2024.
100 Clinical Results associated with Centre Hospitalier Félix-Guyon
0 Patents (Medical) associated with Centre Hospitalier Félix-Guyon
100 Deals associated with Centre Hospitalier Félix-Guyon
100 Translational Medicine associated with Centre Hospitalier Félix-Guyon